Literature DB >> 25617968

A prospective study of blood splatter in ENT.

Raj Lakhani1, Yiwen Loh, Ting Ting Zhang, Prasad Kothari.   

Abstract

Surgeons face an occupational risk of daily exposure to blood and body fluids. Potential sources of infection include sharps injuries and mucocutaneous contact. The transmission of blood-borne viruses, in particular human immunodeficiency virus (HIV), Hepatitis B and Hepatitis C from the patient to healthcare workers is well documented in the literature. We studied the incidence and degree of blood splash in all otolaryngology (ENT) procedures undertaken in a single unit over a 12 week period. In addition, we investigated which intraoperative factors might predict the degree of splash. We undertook a prospective, non-blinded study of 102 patients undergoing a range of 'routine' elective ENT within one department over 12 weeks. A surgical mask with visor attached was worn in all procedures. Following each procedure, all splatter masks were collected and examined macroscopically and microscopically for blood splash. In addition, the procedure performed, technique used, total blood loss, operating time and grade of surgeon was noted. 54% of procedures resulted in splash mask contamination. The median number of splash spots per mask was 4.7 (range 0-63). Tonsillectomy was the most commonly performed procedure, accounting for over one-third of total procedures investigated. Each mask had an average of 8.2 splash marks. Tonsillectomy had a splash rate of 76.9%. Although the risk of developing HIV is low the operating surgeon has a duty to take all precautions to protect themselves during a procedure and therefore a protective mask and visor or suitable goggles must be worn.

Entities:  

Mesh:

Year:  2015        PMID: 25617968     DOI: 10.1007/s00405-014-3469-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  HIV-1 infection transmitted by serum droplets into the eye: a case report.

Authors:  J Eberle; J Habermann; L G Gürtler
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

2.  The incidence of potential conjunctival contamination in tonsillectomy.

Authors:  G Kelly; P Gana; T Nielsen; F MacGregor
Journal:  J R Coll Surg Edinb       Date:  2000-10

3.  Blood splash and tonsillectomy: an underestimated hazard to the otolaryngologist.

Authors:  I J Keogh; S W Hone; M Colreavey; M Walsh
Journal:  J Laryngol Otol       Date:  2001-06       Impact factor: 1.469

4.  The occupational viral risk run by French surgeons: a disturbing perspective.

Authors:  J L Caillot; E J Voigloi; F N Gilly; J Fabry
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

5.  Blood splash from different diathermy instruments during tonsillectomy.

Authors:  B C Hanna; P Thompson; C Smyth; G Gallagher
Journal:  J Laryngol Otol       Date:  2006-07-26       Impact factor: 1.469

6.  Blood and body fluid splashes during surgery--the need for eye protection and masks.

Authors:  C G Davies; M N Khan; A S K Ghauri; C J Ranaboldo
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

7.  Incidence and prevention of conjunctival contamination with blood during hazardous surgical procedures.

Authors:  A E Hinton; R C Herdman; M S Timms
Journal:  Ann R Coll Surg Engl       Date:  1991-07       Impact factor: 1.891

8.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

9.  The risk of eye splash injuries in surgery.

Authors:  S Marasco; S Woods
Journal:  Aust N Z J Surg       Date:  1998-11

Review 10.  Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases.

Authors:  Arnaud Tarantola; Dominique Abiteboul; Anne Rachline
Journal:  Am J Infect Control       Date:  2006-08       Impact factor: 2.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.